Research Reports

Key takeaways

Melinda Lackey appointed General Counsel and SVP of Legal Affairs, bringing nearly two decades of biopharmaceutical legal and IP experience.

Employment terms include a $321,000 annual base salary and eligibility for an annual bonus up to 35% of base salary.

Lackey received an initial equity grant of an option to purchase 45,000 shares of common stock at fair market value.

Severance provisions offer six months of base salary and COBRA coverage in the event of involuntary termination without cause.

Full analysis

Melinda Lackey was appointed as General Counsel and Senior Vice President of Legal Affairs, reporting to CEO Michael Handley. She brings significant experience from prior roles at Alaunos Therapeutics and Kuur Therapeutics, focusing on IP strategy and clinical-stage biopharmaceutical development. Her compensation package includes a $321,000 base salary, a discretionary bonus target of up to 35%, and an initial stock option grant for 45,000 shares. The employment agreement stipulates 'at-will' employment and provides for severance benefits equivalent to six months of base salary and COBRA coverage in the event of termination without cause or resignation for good reason, contingent on a six-month employment duration.

TIVC · Valion Bio, Inc.

Summary

Key takeaways

Full analysis